ID   RAD18_HUMAN             Reviewed;         495 AA.
AC   Q9NS91; Q58F55; Q9NRT6;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=E3 ubiquitin-protein ligase RAD18;
DE            EC=2.3.2.27;
DE   AltName: Full=Postreplication repair protein RAD18;
DE            Short=hHR18;
DE            Short=hRAD18;
DE   AltName: Full=RING finger protein 73;
DE   AltName: Full=RING-type E3 ubiquitin transferase RAD18 {ECO:0000305};
GN   Name=RAD18; Synonyms=RNF73;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-302.
RC   TISSUE=Placenta;
RX   PubMed=10884424; DOI=10.1073/pnas.97.14.7927;
RA   Tateishi S., Sakuraba Y., Masuyama S., Inoue H., Yamaizumi M.;
RT   "Dysfunction of human Rad18 results in defective postreplication
RT   repair and hypersensitivity to multiple mutagens.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:7927-7932(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-302.
RX   PubMed=10908344; DOI=10.1093/nar/28.14.2847;
RA   Xin H., Lin W., Sumanasekera W., Zhang Y., Wu X., Wang Z.;
RT   "The human RAD18 gene product interacts with HHR6A and HHR6B.";
RL   Nucleic Acids Res. 28:2847-2854(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-302.
RA   Jang Y., Chae S.;
RT   "Identification of human RAD18 (hHR18), a homolog of yeast RAD18.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-302.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-6; GLN-302 AND
RP   VAL-307.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-302.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SLF1, AND SUBCELLULAR LOCATION.
RX   PubMed=15632077; DOI=10.1128/MCB.25.2.779-788.2005;
RA   Adams D.J., van der Weyden L., Gergely F.V., Arends M.J., Ng B.L.,
RA   Tannahill D., Kanaar R., Markus A., Morris B.J., Bradley A.;
RT   "BRCTx is a novel, highly conserved RAD18-interacting protein.";
RL   Mol. Cell. Biol. 25:779-788(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   INTERACTION WITH SHPRH.
RX   PubMed=17130289; DOI=10.1083/jcb.200606145;
RA   Motegi A., Sood R., Moinova H., Markowitz S.D., Liu P.P., Myung K.;
RT   "Human SHPRH suppresses genomic instability through proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   J. Cell Biol. 175:703-708(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH SHPRH.
RX   PubMed=17108083; DOI=10.1073/pnas.0608595103;
RA   Unk I., Hajdu I., Fatyol K., Szakal B., Blastyak A., Bermudez V.,
RA   Hurwitz J., Prakash L., Prakash S., Haracska L.;
RT   "Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent
RT   polyubiquitylation of proliferating cell nuclear antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:18107-18112(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; THR-118 AND
RP   SER-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   INTERACTION WITH HLTF.
RX   PubMed=18316726; DOI=10.1073/pnas.0800563105;
RA   Unk I., Hajdu I., Fatyol K., Hurwitz J., Yoon J.-H., Prakash L.,
RA   Prakash S., Haracska L.;
RT   "Human HLTF functions as a ubiquitin ligase for proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3768-3773(2008).
RN   [16]
RP   INTERACTION WITH HLTF.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X.,
RA   Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and
RT   SHPRH prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-103, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-471, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-471, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   FUNCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21659603; DOI=10.1126/science.1203430;
RA   Cotta-Ramusino C., McDonald E.R. III, Hurov K., Sowa M.E.,
RA   Harper J.W., Elledge S.J.;
RT   "A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1
RT   interacting protein required for ATR signaling.";
RL   Science 332:1313-1317(2011).
RN   [22]
RP   INTERACTION WITH SLF1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   SER-442 AND SER-444.
RX   PubMed=22036607; DOI=10.1016/j.dnarep.2011.10.012;
RA   Liu T., Chen H., Kim H., Huen M.S., Chen J., Huang J.;
RT   "RAD18-BRCTx interaction is required for efficient repair of UV-
RT   induced DNA damage.";
RL   DNA Repair 11:131-138(2012).
RN   [23]
RP   UBIQUITIN-BINDING, AND LR MOTIF.
RX   PubMed=22742833; DOI=10.1016/j.molcel.2012.05.045;
RA   Panier S., Ichijima Y., Fradet-Turcotte A., Leung C.C., Kaustov L.,
RA   Arrowsmith C.H., Durocher D.;
RT   "Tandem protein interaction modules organize the ubiquitin-dependent
RT   response to DNA double-strand breaks.";
RL   Mol. Cell 47:383-395(2012).
RN   [24]
RP   INTERACTION WITH SPRTN.
RX   PubMed=22681887; DOI=10.1016/j.molcel.2012.05.020;
RA   Centore R.C., Yazinski S.A., Tse A., Zou L.;
RT   "Spartan/C1orf124, a reader of PCNA ubiquitylation and a regulator of
RT   UV-induced DNA damage response.";
RL   Mol. Cell 46:625-635(2012).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; THR-118;
RP   SER-122; SER-125; SER-142; SER-158; SER-164; SER-322; SER-471 AND
RP   SER-483, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-376, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [28]
RP   INTERACTION WITH SLF1; SLF2 AND SMC5, SUBCELLULAR LOCATION,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF SER-442 AND
RP   SER-444.
RX   PubMed=25931565; DOI=10.1126/science.1253671;
RA   Raeschle M., Smeenk G., Hansen R.K., Temu T., Oka Y., Hein M.Y.,
RA   Nagaraj N., Long D.T., Walter J.C., Hofmann K., Storchova Z., Cox J.,
RA   Bekker-Jensen S., Mailand N., Mann M.;
RT   "DNA repair. Proteomics reveals dynamic assembly of repair complexes
RT   during bypass of DNA cross-links.";
RL   Science 348:1253671-1253671(2015).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-99, SUBUNIT, AND
RP   MUTAGENESIS OF ILE-27.
RX   PubMed=21549715; DOI=10.1016/j.jmb.2011.04.051;
RA   Huang A., Hibbert R.G., de Jong R.N., Das D., Sixma T.K., Boelens R.;
RT   "Symmetry and asymmetry of the RING-RING dimer of Rad18.";
RL   J. Mol. Biol. 410:424-435(2011).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase involved in postreplication
CC       repair of UV-damaged DNA. Postreplication repair functions in gap-
CC       filling of a daughter strand on replication of damaged DNA.
CC       Associates to the E2 ubiquitin conjugating enzyme UBE2B to form
CC       the UBE2B-RAD18 ubiquitin ligase complex involved in mono-
CC       ubiquitination of DNA-associated PCNA on 'Lys-164'. Has ssDNA
CC       binding activity. {ECO:0000269|PubMed:17108083,
CC       ECO:0000269|PubMed:21659603}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homodimer (PubMed:21549715). Interacts with UBE2A and
CC       UBE2B, one homodimer binding one molecule of UBE2B. Interacts with
CC       SHPRH (PubMed:17130289, PubMed:17108083). Interacts with HLTF
CC       (PubMed:18316726, PubMed:18719106). Interacts with SPRTN; leading
CC       to enhance chromatin association of RAD18 and RAD18-mediated PCNA
CC       ubiquitination and translesion DNA synthesis (PubMed:22681887).
CC       Interacts (via C-terminus and phosphorylated form) with SLF1 (via
CC       BRCT domains); this interaction is required for efficient repair
CC       of UV-induced DNA damage (PubMed:15632077, PubMed:22036607,
CC       PubMed:25931565). Interacts with SLF2 (PubMed:25931565). Interacts
CC       with SMC5; this interaction is increased in a SLF1 or SLF2-
CC       dependent manner (PubMed:25931565). {ECO:0000269|PubMed:15632077,
CC       ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:17130289,
CC       ECO:0000269|PubMed:18316726, ECO:0000269|PubMed:18719106,
CC       ECO:0000269|PubMed:21549715, ECO:0000269|PubMed:22036607,
CC       ECO:0000269|PubMed:22681887, ECO:0000269|PubMed:25931565}.
CC   -!- INTERACTION:
CC       Q86VP1:TAX1BP1; NbExp=5; IntAct=EBI-2339393, EBI-529518;
CC       P49459:UBE2A; NbExp=3; IntAct=EBI-2339393, EBI-2339348;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15632077,
CC       ECO:0000269|PubMed:22036607, ECO:0000269|PubMed:25931565}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:15632077}. Note=Associates with chromatin
CC       (PubMed:25931565). Colocalizes with SLF1 in the nucleus and to
CC       centrosomes (PubMed:15632077). Relocalizes with SLF1 to nuclear
CC       foci in response to DNA damage (PubMed:22036607). Accumulates with
CC       the SLF1-SLF2 and SMC5-SMC6 complexes at replication-coupled DNA
CC       interstrand repair and DNA double-strand breaks (DSBs) sites on
CC       chromatin in a ubiquitin-dependent manner (PubMed:25931565).
CC       {ECO:0000269|PubMed:15632077, ECO:0000269|PubMed:22036607,
CC       ECO:0000269|PubMed:25931565}.
CC   -!- SIMILARITY: Belongs to the RAD18 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/rad18/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB035274; BAA99284.1; -; mRNA.
DR   EMBL; AF169796; AAF80856.1; -; mRNA.
DR   EMBL; AY004333; AAF86618.1; -; mRNA.
DR   EMBL; AK023075; BAB14392.1; -; mRNA.
DR   EMBL; AY961989; AAX44049.1; -; Genomic_DNA.
DR   EMBL; AC008151; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC034186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001302; AAH01302.1; -; mRNA.
DR   CCDS; CCDS2571.1; -.
DR   RefSeq; NP_064550.3; NM_020165.3.
DR   UniGene; Hs.375684; -.
DR   PDB; 2MRE; NMR; -; B=198-227.
DR   PDB; 2MRF; NMR; -; A=198-227.
DR   PDB; 2Y43; X-ray; 1.80 A; A/B=1-99.
DR   PDB; 2YBF; X-ray; 2.00 A; B=340-366.
DR   PDBsum; 2MRE; -.
DR   PDBsum; 2MRF; -.
DR   PDBsum; 2Y43; -.
DR   PDBsum; 2YBF; -.
DR   ProteinModelPortal; Q9NS91; -.
DR   SMR; Q9NS91; -.
DR   BioGrid; 121212; 87.
DR   DIP; DIP-29831N; -.
DR   IntAct; Q9NS91; 37.
DR   MINT; MINT-3073564; -.
DR   STRING; 9606.ENSP00000264926; -.
DR   iPTMnet; Q9NS91; -.
DR   PhosphoSitePlus; Q9NS91; -.
DR   BioMuta; RAD18; -.
DR   DMDM; 313104165; -.
DR   EPD; Q9NS91; -.
DR   MaxQB; Q9NS91; -.
DR   PaxDb; Q9NS91; -.
DR   PeptideAtlas; Q9NS91; -.
DR   PRIDE; Q9NS91; -.
DR   DNASU; 56852; -.
DR   Ensembl; ENST00000264926; ENSP00000264926; ENSG00000070950.
DR   GeneID; 56852; -.
DR   KEGG; hsa:56852; -.
DR   UCSC; uc003brd.4; human.
DR   CTD; 56852; -.
DR   DisGeNET; 56852; -.
DR   GeneCards; RAD18; -.
DR   H-InvDB; HIX0003022; -.
DR   HGNC; HGNC:18278; RAD18.
DR   HPA; HPA006716; -.
DR   HPA; HPA006724; -.
DR   HPA; HPA008752; -.
DR   MIM; 605256; gene.
DR   neXtProt; NX_Q9NS91; -.
DR   OpenTargets; ENSG00000070950; -.
DR   PharmGKB; PA134912253; -.
DR   eggNOG; KOG0287; Eukaryota.
DR   eggNOG; COG5432; LUCA.
DR   GeneTree; ENSGT00390000011230; -.
DR   HOGENOM; HOG000234845; -.
DR   HOVERGEN; HBG054721; -.
DR   InParanoid; Q9NS91; -.
DR   KO; K10627; -.
DR   OMA; ESHINKH; -.
DR   OrthoDB; EOG091G047P; -.
DR   PhylomeDB; Q9NS91; -.
DR   TreeFam; TF101214; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   SIGNOR; Q9NS91; -.
DR   UniPathway; UPA00143; -.
DR   GeneWiki; RAD18; -.
DR   GenomeRNAi; 56852; -.
DR   PRO; PR:Q9NS91; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000070950; -.
DR   CleanEx; HS_RAD18; -.
DR   ExpressionAtlas; Q9NS91; baseline and differential.
DR   Genevisible; Q9NS91; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0042405; C:nuclear inclusion body; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0097505; C:Rad6-Rad18 complex; IBA:GO_Central.
DR   GO; GO:0005657; C:replication fork; IDA:UniProtKB.
DR   GO; GO:0035861; C:site of double-strand break; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:MGI.
DR   GO; GO:0031593; F:polyubiquitin binding; IDA:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IPI:UniProtKB.
DR   GO; GO:0043142; F:single-stranded DNA-dependent ATPase activity; IBA:GO_Central.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0000403; F:Y-form DNA binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0006281; P:DNA repair; NAS:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; IDA:UniProtKB.
DR   GO; GO:0051984; P:positive regulation of chromosome segregation; IMP:UniProtKB.
DR   GO; GO:0006301; P:postreplication repair; IBA:GO_Central.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:MGI.
DR   GO; GO:0006513; P:protein monoubiquitination; IBA:GO_Central.
DR   GO; GO:0009411; P:response to UV; IBA:GO_Central.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 1.10.720.30; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003034; SAP_dom.
DR   InterPro; IPR006642; Znf_Rad18_put.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF02037; SAP; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00513; SAP; 1.
DR   SMART; SM00734; ZnF_Rad18; 1.
DR   PROSITE; PS50800; SAP; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Cytoskeleton;
KW   DNA damage; DNA repair; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    495       E3 ubiquitin-protein ligase RAD18.
FT                                /FTId=PRO_0000056149.
FT   DOMAIN      248    282       SAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00186}.
FT   ZN_FING      25     64       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     201    224       UBZ-type.
FT   MOTIF       232    240       LR motif.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      99     99       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     103    103       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     118    118       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     122    122       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     164    164       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     471    471       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     483    483       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    376    376       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VARIANT       6      6       E -> A (in dbSNP:rs45520133).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023423.
FT   VARIANT     302    302       R -> Q (in dbSNP:rs373572).
FT                                {ECO:0000269|PubMed:10884424,
FT                                ECO:0000269|PubMed:10908344,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023424.
FT   VARIANT     307    307       I -> V (in dbSNP:rs45569933).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023425.
FT   MUTAGEN      27     27       I->A: Lower activity toward PCNA
FT                                monoubiquitination.
FT                                {ECO:0000269|PubMed:21549715}.
FT   MUTAGEN     442    442       S->A: Does not interact with SLF1 and is
FT                                defective in restoring cell survival
FT                                after DNA damage; when associated with A-
FT                                444. {ECO:0000269|PubMed:22036607,
FT                                ECO:0000269|PubMed:25931565}.
FT   MUTAGEN     444    444       S->A: Does not interact with SLF1 and is
FT                                defective in restoring cell survival
FT                                after DNA damage; when associated with A-
FT                                442. {ECO:0000269|PubMed:22036607,
FT                                ECO:0000269|PubMed:25931565}.
FT   CONFLICT    191    191       P -> L (in Ref. 2; AAF80856).
FT                                {ECO:0000305}.
FT   CONFLICT    482    484       ESA -> GKC (in Ref. 2; AAF80856).
FT                                {ECO:0000305}.
FT   HELIX        11     16       {ECO:0000244|PDB:2Y43}.
FT   HELIX        17     22       {ECO:0000244|PDB:2Y43}.
FT   TURN         26     28       {ECO:0000244|PDB:2Y43}.
FT   STRAND       33     37       {ECO:0000244|PDB:2Y43}.
FT   TURN         39     41       {ECO:0000244|PDB:2Y43}.
FT   STRAND       44     46       {ECO:0000244|PDB:2Y43}.
FT   HELIX        47     54       {ECO:0000244|PDB:2Y43}.
FT   TURN         61     63       {ECO:0000244|PDB:2Y43}.
FT   HELIX        69     71       {ECO:0000244|PDB:2Y43}.
FT   HELIX        76     90       {ECO:0000244|PDB:2Y43}.
FT   STRAND      201    204       {ECO:0000244|PDB:2MRE}.
FT   TURN        205    208       {ECO:0000244|PDB:2MRE}.
FT   STRAND      209    212       {ECO:0000244|PDB:2MRE}.
FT   HELIX       213    223       {ECO:0000244|PDB:2MRE}.
FT   HELIX       342    345       {ECO:0000244|PDB:2YBF}.
FT   HELIX       347    358       {ECO:0000244|PDB:2YBF}.
SQ   SEQUENCE   495 AA;  56223 MW;  744A053A50C65DD7 CRC64;
     MDSLAESRWP PGLAVMKTID DLLRCGICFE YFNIAMIIPQ CSHNYCSLCI RKFLSYKTQC
     PTCCVTVTEP DLKNNRILDE LVKSLNFARN HLLQFALESP AKSPASSSSK NLAVKVYTPV
     ASRQSLKQGS RLMDNFLIRE MSGSTSELLI KENKSKFSPQ KEASPAAKTK ETRSVEEIAP
     DPSEAKRPEP PSTSTLKQVT KVDCPVCGVN IPESHINKHL DSCLSREEKK ESLRSSVHKR
     KPLPKTVYNL LSDRDLKKKL KEHGLSIQGN KQQLIKRHQE FVHMYNAQCD ALHPKSAAEI
     VREIENIEKT RMRLEASKLN ESVMVFTKDQ TEKEIDEIHS KYRKKHKSEF QLLVDQARKG
     YKKIAGMSQK TVTITKEDES TEKLSSVCMG QEDNMTSVTN HFSQSKLDSP EELEPDREED
     SSSCIDIQEV LSSSESDSCN SSSSDIIRDL LEEEEAWEAS HKNDLQDTEI SPRQNRRTRA
     AESAEIEPRN KRNRN
//
